Kenvue to Announce Third Quarter 2024 Results on November 7, 2024
Kenvue Inc. (NYSE: KVUE), the world's largest pure-play consumer health company by revenue, has announced it will release its third quarter 2024 financial results on November 7, 2024, before the market opens. The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss the results.
Investors can access the conference call by dialing 877-407-8835 from the U.S. or +1 201-689-8779 from international locations. A live webcast will be available at investors.kenvue.com, with a replay accessible after the event. Kenvue's portfolio includes well-known brands such as Aveeno®, BAND-AID®, Johnson's®, Listerine®, Neutrogena®, and Tylenol®.
Kenvue Inc. (NYSE: KVUE), la più grande azienda al mondo nel settore della salute dei consumatori per fatturato, ha annunciato che rilascerà i suoi risultati finanziari del terzo trimestre 2024 il 7 novembre 2024, prima dell'apertura del mercato. L'azienda organizzerà una conferenza telefonica e un webcast alle 8:00 a.m. Eastern Time per discutere i risultati.
Gli investitori possono partecipare alla conferenza telefonica componendo il numero 877-407-8835 dagli Stati Uniti oppure +1 201-689-8779 da località internazionali. Sarà disponibile un webcast dal vivo su investors.kenvue.com, con una registrazione accessibile dopo l'evento. Il portafoglio di Kenvue include marchi noti come Aveeno®, BAND-AID®, Johnson's®, Listerine®, Neutrogena® e Tylenol®.
Kenvue Inc. (NYSE: KVUE), la compañía de salud del consumidor más grande del mundo por ingresos, ha anunciado que publicará sus resultados financieros del tercer trimestre de 2024 el 7 de noviembre de 2024, antes de la apertura del mercado. La empresa realizará una conferencia telefónica y un webcast a las 8:00 a.m. Eastern Time para discutir los resultados.
Los inversores pueden acceder a la conferencia telefónica marcando el 877-407-8835 desde EE. UU. o +1 201-689-8779 desde ubicaciones internacionales. Habrá un webcast en vivo disponible en investors.kenvue.com, con una repetición accesible después del evento. El portafolio de Kenvue incluye marcas reconocidas como Aveeno®, BAND-AID®, Johnson's®, Listerine®, Neutrogena® y Tylenol®.
Kenvue Inc. (NYSE: KVUE)는 매출 기준으로 세계에서 가장 큰 소비자 건강 회사로, 2024년 3분기 재무 결과를 2024년 11월 7일에 시장이 열리기 전에 발표할 것이라고 발표했습니다. 이 회사는 결과를 논의하기 위해 동부 표준시 기준 8:00 a.m.에 컨퍼런스 콜과 웹캐스트를 개최할 것입니다.
투자자들은 미국에서 877-407-8835로 전화하거나 국제적으로는 +1 201-689-8779를 다이얼해 컨퍼런스 콜에 접속할 수 있습니다. investors.kenvue.com에서 생중계 웹캐스트가 제공되며, 이벤트 후에는 다시 보기 기능이 제공됩니다. Kenvue의 포트폴리오에는 Aveeno®, BAND-AID®, Johnson's®, Listerine®, Neutrogena® 및 Tylenol®과 같은 잘 알려진 브랜드가 포함되어 있습니다.
Kenvue Inc. (NYSE: KVUE), la plus grande entreprise de santé grand public au monde en termes de revenus, a annoncé qu'elle publiera ses résultats financiers du troisième trimestre 2024 le 7 novembre 2024, avant l'ouverture du marché. L'entreprise organisera une conférence téléphonique et un webcast à 8h00, heure de l'Est pour discuter des résultats.
Les investisseurs peuvent accéder à la conférence téléphonique en composant le 877-407-8835 depuis les États-Unis ou le +1 201-689-8779 depuis l'international. Un webcast en direct sera disponible sur investors.kenvue.com, avec une rediffusion accessible après l'événement. Le portefeuille de Kenvue comprend des marques bien connues telles que Aveeno®, BAND-AID®, Johnson's®, Listerine®, Neutrogena® et Tylenol®.
Kenvue Inc. (NYSE: KVUE), das größte Unternehmen der Welt im Bereich Konsumgesundheit nach Umsatz, hat angekündigt, dass es seine Finanzergebnisse für das dritte Quartal 2024 am 7. November 2024 vor Markteröffnung bekannt geben wird. Das Unternehmen wird eine Telefonkonferenz und ein Webcast um 8:00 Uhr Eastern Time abhalten, um die Ergebnisse zu besprechen.
Investoren können an der Telefonkonferenz teilnehmen, indem sie 877-407-8835 aus den USA oder +1 201-689-8779 aus internationalen Standorten wählen. Ein Live-Webcast wird unter investors.kenvue.com verfügbar sein, mit einer Aufzeichnung, die nach der Veranstaltung zugänglich ist. Das Portfolio von Kenvue umfasst bekannte Marken wie Aveeno®, BAND-AID®, Johnson's®, Listerine®, Neutrogena® und Tylenol®.
- Kenvue is the world's largest pure-play consumer health company by revenue
- The company owns iconic, science-backed brands recommended by healthcare professionals
- None.
The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss its financial results. The conference call can be accessed by dialing 877-407-8835 from the
About Kenvue
Kenvue is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson’s®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we believe in the extraordinary power of everyday care and our teams work every day to put that power in consumers’ hands and earn a place in their hearts and homes. Learn more at www.kenvue.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241018142333/en/
Investor Relations:
Sofya Tsinis
Kenvue_IR@Kenvue.com
Media Relations:
Melissa Witt
Media@Kenvue.com
Source: Kenvue
FAQ
When will Kenvue (KVUE) release its Q3 2024 financial results?
How can investors access Kenvue's (KVUE) Q3 2024 earnings call?
What time is Kenvue's (KVUE) Q3 2024 earnings conference call?
What are some of the brands owned by Kenvue (KVUE)?
